Richard Dimbleby Laboratory of Cancer Research
Scientists are focusing on translating basic research into molecular diagnostics for cancer drugs with the aim of improving targeted therapy for cancer patients.
The laboratory is among one of the few in the world which will bring together research scientists from different disciplines including advanced optical physics, molecular and cell biology and tumour pathology and clinical cancer treatment; working collaboratively to develop a variety of new technologies in the field of cancer cell and tissue imaging, which researchers hope will help evaluate patients’ disease progression.
The Centre is funded by the charity Dimbleby Cancer Care, set up in the memory of Richard Dimbleby. The charity aims to help develop better care services for those living with cancer, and to research the causes of cancer.
In line with the establishment of a comprehensive cancer centre at the College’s Guy’s Campus, the Dimbleby Laboratories have been re-located to Guy’s and newly refurbished to allow the researchers to focus specifically on drug discovery for cancer treatment, and also to adopt a more personalised approach to drug therapy, with new technologies that are able to distinguish which patients will benefit most effectively from certain drugs.
Professor Tony Ng who currently holds the Dimbleby Cancer Chair at King’s and is Director of the Laboratory comments: ‘Basic science and laboratory-based research is fundamental to improving patient care and treatment in the future. By collaborating with health professionals and scientists from a range of disciplines, I hope to ensure that my research moves from bench to bedside and provides benefits to patients as quickly as possible.’
The laboratories offer PhD training for oncologists and cancer surgeons and contribute to the new King’s College London Masters research degree in Translational Cancer Medicine. These research programmes are laboratory-based and will offer valuable experience for medical students, basic science graduates who have an interest in specialising in cancer research, as well as for qualified oncologists and surgeons, in gaining knowledge about new therapies in order to apply more targeted and effective treatment for patients.